Pharmacists can reduce COVID-19 vaccine hesitancy through honest, nonjudgmental communication and by using every patient touchpoint as an opportunity to offer vaccination.
|Videos|September 14, 2021
Pharmacists Can Help Tackle Flu Vaccine Hesitancy
Author(s)Ashley Gallagher, Editor
Aaron Clark, DO, medical director of value based care at Ohio State University and clinical associate professor of family medicine, discusses vaccine hesitancy and racial disparities around flu vaccinations.
Advertisement
In an interview with Pharmacy Times®, Aaron Clark, DO, medical director of value based care at Ohio State University and clinical associate professor of family medicine, discusses vaccine hesitancy and racial disparities around flu vaccinations.
He addresses why people might be hesitant to get the flu vaccine, why People of Color are less likely to get the vaccination, and how pharmacists can help promote the benefits of vaccinations.
Advertisement
Related to this article
Expert Q&A: Geisinger Investigator Discusses Low Flu Vaccination Rates, ICU Findings in Older Adults
A study author explains how pharmacists can help close vaccination gaps in rural communities and what lower ICU admission rates among vaccinated older adults may mean.
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
Twice-daily metronidazole dosing had outcomes comparable with those of thrice-daily dosing for confirmed anaerobic infections, minimizing drug exposure and cost while maintaining clinical efficacy.
Treated patients also had fewer post-acute hospitalizations and deaths, but individuals without risk factors saw no benefit.
Doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd (Voceryq) targets HPV-6 and HPV-11 to reduce the surgical burden for adults with recurrent respiratory papillomatosis, a rare airway disease.
Caitlin McClain, a nurse and Clostridioides difficile infection (CDI) survivor, says pharmacists are well placed to help patients tell routine antibiotic adverse effects apart from CDI, which could lead to earlier diagnosis.
Advertisement
Advertisement
Trending on Pharmacy Times
1
CVS Health to Split Into 2 Public Companies, Separating Retail and Specialty Pharmacy
2
Two Gene Therapy Approvals Expand Options for Rare Immune Disorders as Access Challenges Persist
3
Is Less More? Comparing Metronidazole Dosing in Confirmed Anaerobic Infections
4
RSV Hospitalization Linked to Higher Short-Term Risk of Invasive Pneumococcal Disease
5